organ transplant ppt
TRANSCRIPT
Organ TransplantationProfessor Richard Frank, MSN, RN
A Few Key Historical Facts:
• 1954: First successful kidney transplant performed
• 1968: Uniform Anatomical Gift act signed
• 1968: First organ procurement organization (OPO) established, New England Organ Bank (based in Boston)
• 1983: FDA approved cyclosporine anti-rejection medication
• 1984: National Organ Transplant Act operated by UNOS
• 1998: Plasmapheresis introduced; enabled kidney transplants in patients whose blood group/antibodies incompatible with donor
• 1998: First successful hand transplant performed in France
• 2011: First successful full face transplant performed in the US (Boston, MA)
1968: Uniform Anatomical Gift • Establishes uniform organ donor card as a legal document.
• Next of kin can donate without the presence of a donor card.
• Website
1984: National Organ Transplant Act • National Organ Transplant Act (NOTA) maintained by the United
Network for Organ Sharing (UNOS)
• Authorizes financial support for Organ Procurement Organizations (OPOs); prohibits buying or selling of organs in the United States.
• Website
1986: Required Request Law
• Requires hospitals to develop policies to identify patients as potential donors
• Requires hospitals to approach families regarding organ donation
1998: National Conditions of Participation Legislation• Requires hospitals to refer all deaths and imminent deaths to the
local procurement organization.
LET’S REVIEW …
Uniform Anatomical Gift: __________________________________________________________________________________________________________________
National Organ Transplant Act: ________________________________________________________
________________________________________________________
Required Request Law: ________________________________________________________
________________________________________________________
National Conditions of Participation Legislation: ________________________________________________________
________________________________________________________
Organ & Tissue Transplantation
• Cornea
• Kidneys
• Skin
• Bone marrow
• Heart and heart valves
• Intestine
• Bone
• Lung
• Liver
• Pancreas
Who Can Donate?• Direct Donation
• Non-Direct Donation
• Living Donor
• Cadaver Donor
Determining Brain Death & the Uniform Brain Death Act• Irreversible coma
• Unresponsive to all stimuli
• Absence of spontaneous muscle activity
• Irreversible cessation of circulatory and respiratory function
• Isoelectric electroencephalogram (EEG) for 30 minutes
The Different Types of Organ Donors:
• Types of Living Donor Transplants• Kidney (entire organ)• Liver (segment)• Lung (lobe)• Intestine (portion)• Pancreas (portion)• After brain death
• Kidney• Heart• Liver • Lungs• Pancreas• Intestine• Heart valves• Connective tissue
• Cadaver• After natural death
• Cornea• Bone• Skin • Blood vessels
Living-Relative-Stranger
Cadaver
Types of Transplants
• Autograft
• Allograft
• Isograft
• Xenograft
LET’S REVIEW …Who Can Donate? _______________________________________________________
________________________________________________________
How is Brain Death Determined? ________________________________________________________
________________________________________________________
Uniform Determination of Death Act:
________________________________________________________
________________________________________________________
What are the Different Type of Organ Donors? ________________________________________________________
________________________________________________________
What are the Different Types of Transplants? ________________________________________________________
________________________________________________________
Liver Transplant• End-stage liver disease
• Chronic viral hepatitis
• Live and cadaver donors
• Post-op complications• Rejection
• Infection
• Nursing Care• Neuro assessment
• Hemorrhage
• Respiratory assessment
• Urinary output
• Labs
• Vital signs
• Assess for s/s of infection and rejection
Heart Transplant
•End-stage heart failure• Patient dependant on
inotropes• Refractory cardiogenic
shock
•Cardiomyopathy
• Inoperable CAD
Lung Transplant • End-stage lung disease
• 4 types of surgery• Single lung• Bilateral lung• Heart-lung• Lobe transplant
• Post-op care • Ventillatory support• Hemodynamic monitoring• Immunosuppressive therapy• Monitor for s/s of infection
and rejection
• Website
LET’S REVIEW …LIVER Transplant:
_______________________________________________________
_______________________________________________________
_______________________________________________________
LUNG Transplant:
_______________________________________________________
_______________________________________________________
_______________________________________________________
HEART Transplant: ________________________________________________________
________________________________________________________
________________________________________________________
How are organs allocated?
•ABO blood type
•Medical urgency
•Time on the waiting list
•Geographic location
United Network for Organ Sharing (UNOS)• Coordinates the organ transplant system in the United States
• Increases public awareness of the critical need for donated organs and tissues
• Maintains the national organ transplant waiting list• Coordinates the matching and distribution of donated
organs
• Collects and reports data on transplant recipients, donors and outcomes
Organ Procurement Organizations (OPOs)•Responsible for recovering the organ and keeping it
viable until it is transplanted, and transporting the organ to the recipient
•New England Organ Bank: oldest OPO in the US• Covers the 6 New England states and Bermuda• OPO procurement coordinator will take over the care of
the donor until surgery
Organ Donor Waiting list:
Data source: http://optn.transplant.hrsa.gov/
Prioritizing Patients for Transplantation• Each organ type has its own individual distribution policy
• Patients who are close biological matches with a particular donor offer are given priority
• Patients whose medical status is most urgent receive priority
• Organs are offered locally first
• Children are often offered priority
• Wait time is used to break ties between patients who are similar
UNOS Regional Map Region 1 - Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island
Region 2 - Delaware, District of Columbia, Maryland, New Jersey, Pennsylvania, Northern Virginia,
West Virginia
Region 3 - Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, Puerto Rico
Region 4 - Oklahoma, Texas
Region 5 - Arizona, California, Nevada, New Mexico, Utah
Region 6 - Alaska, Hawaii, Idaho, Montana, Oregon, Washington
Region 7 - Illinois, Minnesota, North Dakota, South Dakota, Wisconsin
Region 8 - Colorado, Iowa, Kansas, Missouri, Nebraska, Wyoming
Region 9 - New York, Vermont
Region 10 - Indiana, Michigan, Ohio
Region 11 - Kentucky, North Carolina, South Carolina, Tennessee, Virginia
LET’S REVIEW …ORGAN ALLOCATION: ________________________________________________________
________________________________________________________
________________________________________________________
ONUS:
________________________________________________________
________________________________________________________
ORGAN PRIORITIZATION FOR TRANSPLANTATION: ________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
UNOS REGIONS: ________________________________________________________
________________________________________________________
Organ offer process
•Deceased organ donor is identified
•UNOS notifies transplant team of the first person on the match list•Potential recipient must be available 24 hours a
day •Given one hour to accept or turn down the organ
• Evaluated for presence of infection
• Admit to hospital for pre-op
Blood type matching
Human leukocyte antigen typing (HLA)• HLA antigens are detected on the surface of White Blood Cells.
• Regulates how the body recognizes and rejects foreign tissue.
• There are 5 loci with 2 antigens at each locus (total of 6 antigens)• A, B, C, D and DR
• The goal is to match as many antigens as possible
• Certain organs and tissue transplants require a closer match than other organs
Human leukocyte antigen (HLA) type
LET’S REVIEW …ORGAN OFFERING:________________________________________
________________________________________________________
________________________________________________________
UNOS & OPOs: ___________________________________________
________________________________________________________
________________________________________________________
PRIORITIZATION: _________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
Transplant RejectionTransplant rejection
• Hyperacute• Occurs minutes to hours after
transplantation
• No treatment (organ must be removed)
• Acute• Occurs days (one week) to
months after transplantation
• T- cytotoxic lymphocytes attack the transplanted organ
• Chronic• Occurs over months to years
• Most common in lung transplants
Some Common Signs & Symptoms
• Pain at the site of the transplant
• Feeling ill
• Flu-like symptoms
• Fever
• Weight change
• Swelling
• Decreased urine output
Immunosuppressive Therapy•Triple therapy (all PO/IV)
• Cyclosporine• Prevent a cell-mediated attack (helper T-cells) against the organ
• Corticosteriod: prednisone-methylprednisolone (Solu-Medrol)• Suppress inflammatory response
• Cytotoxic drug: mycophenolate mefetil (CellCept) or cyclophosphamide (Cytoxan)• Suppress immune response by inhibiting proliferation of T and B cells
•Monoclonal Antibodies: muromonab-CD3• Used for preventing and treating acute rejection episodes
•Polyclonal Antibodies: Atgam• Used as induction therapy or to treat acute rejection
Calcineurin inhibitor: Cyclosporine•Most effective immunosuppressant available
•Prevents cell mediated attack against the new organ
•Potentially nephrotoxic
•Avoid grapefruit juice
•Side effects• Nephrotoxicity• Increased risk of infection• Neurotoxicity (seizure activity, tremor)• Hepatotoxicity• Lymphoma• Hypertension• Gingiveal hyperplasia
Corticosteroids: Prednisone, Methylprednisolone, Solu-Medrol
•Very effective in suppressing the inflammatory response but large doses are associated with adverse effects• Altered wound healing• Altered metabolism of fats, proteins, and carbohydrates• Increased blood glucose levels• Emotional disturbance• Osteoparosis• Change in fat distribution: cushingoid appearance
• Moon face
• Increased truncal fat
• Buffalo hump
Cytotoxic Drug: mycophenolate(CellCept)•Suppresses T and B lymphocytes
•Decreases the incidence of graft loss
•Side effects•GI toxicity n/v/d•Neutropenia•Thrombocytopenia• Increased risk of infection• Increased risk of malignancy
Monoclonal Antibodies: muromonab-CD3, orthoclone OKT-3
•Used in preventing and treating acute rejection episodes
•The antiantigen receptor antibody interferes with the function of the T-lymphocytes
•Given IV push 7-14 days
•All T-cells are affected with in minutes of administering the drug and the number of circulating T-cells decrease rapidly
•Associated with terrible side effects
Polyclonal Antibody: Atgam•Used to as induction therapy
•Side effects• Fever• Chills• Muscle and joint pain• Increased heart rate• Back pain• Shortness of breath• Hypotension• Rash• Increased risk of infection
Immunosuppressive Therapy: Side Effects
•Nephrotoxicity
• Increased risk of infection
• Lymphoma
•Hepatotoxicity
•Neutropenia
•Thrombocytopenia
•Diarrhea/nausea/vomiting
LET’S REVIEW …
REJECTION: ______________________________________________
________________________________________________________
IMMUNOSUPPRESSIVE THERAPIES: ___________________________
________________________________________________________
________________________________________________________
____ ____________________________________________________
________________________________________________________
________________________________________________________
IST SIDE EFFECTS: _________________________________________
________________________________________________________
________________________________________________________
Nursing Care of the Transplant Recipient•THE PATIENT
•THE HOME
•THE TRANSPLANT
•INFECTION & REJECTION
Nursing Care of the Transplant Recipient•THE PATIENT:•Hand washing•Assess for infection•Restrict visitors who have minor upper respiratory infections
Nursing Care of the Transplant Recipient•THE HOME•Assess for graft vs host disease•Monitor labs•Reverse or protective isolation
Nursing Care of the Transplant DONOR•THE TRANSPLANT•Adequate nutrition•IV bags and tubing •Invasive lines and catheters
Nursing Care of the Transplant Recipient
•INFECTION & REJECTION•Strict personal hygiene and mouth care•Assess for evidence of rejection•Strict medication regime
LET’S REVIEW …THE PATIENT: _____________________________________________
________________________________________________________
________________________________________________________
THE HOME:_______________________________________________
_________________________________________________________
THE TRANSPLANT: _________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
________________________________________________________
INFECTION & REJECTION: ___________________________________
________________________________________________________